Cargando…

Counterpoint: Postprandial Glucose Levels Are Not a Clinically Important Treatment Target

Detalles Bibliográficos
Autor principal: Davidson, Mayer B.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909085/
https://www.ncbi.nlm.nih.gov/pubmed/20668159
http://dx.doi.org/10.2337/dc10-0712
_version_ 1782184270972846080
author Davidson, Mayer B.
author_facet Davidson, Mayer B.
author_sort Davidson, Mayer B.
collection PubMed
description
format Text
id pubmed-2909085
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-29090852011-08-01 Counterpoint: Postprandial Glucose Levels Are Not a Clinically Important Treatment Target Davidson, Mayer B. Diabetes Care Point/Counterpoint American Diabetes Association 2010-08 /pmc/articles/PMC2909085/ /pubmed/20668159 http://dx.doi.org/10.2337/dc10-0712 Text en © 2010 by the American Diabetes Association. https://creativecommons.org/licenses/by-nc-nd/3.0/Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ (https://creativecommons.org/licenses/by-nc-nd/3.0/) for details.
spellingShingle Point/Counterpoint
Davidson, Mayer B.
Counterpoint: Postprandial Glucose Levels Are Not a Clinically Important Treatment Target
title Counterpoint: Postprandial Glucose Levels Are Not a Clinically Important Treatment Target
title_full Counterpoint: Postprandial Glucose Levels Are Not a Clinically Important Treatment Target
title_fullStr Counterpoint: Postprandial Glucose Levels Are Not a Clinically Important Treatment Target
title_full_unstemmed Counterpoint: Postprandial Glucose Levels Are Not a Clinically Important Treatment Target
title_short Counterpoint: Postprandial Glucose Levels Are Not a Clinically Important Treatment Target
title_sort counterpoint: postprandial glucose levels are not a clinically important treatment target
topic Point/Counterpoint
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909085/
https://www.ncbi.nlm.nih.gov/pubmed/20668159
http://dx.doi.org/10.2337/dc10-0712
work_keys_str_mv AT davidsonmayerb counterpointpostprandialglucoselevelsarenotaclinicallyimportanttreatmenttarget